Related Experiment Video
Updated: Aug 6, 2026
Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Modulation of Nr-13 antideath activity by peptide aptamers
A-L Nouvion1, J Thibaut, O D Lohez
1Equipe Apoptose et Oncogenèse, Institut de Biologie et Chimie des Protéines (IBCP UMR 5086 CNRS/Université claude Bernard Lyon 1), IFR128 BioSciences Lyon-Gerland, Lyon, France.
Abstract:
Tumor cells are characterized by deregulated proliferation and resistance to proapoptotic stimuli. The Bcl-2 family of antiapoptotic proteins is overexpressed in a large number of chemoresistant tumors. Downregulation or inhibition of antiapoptotic proteins might result in the sensitization of cancer cells to chemotherapeutic agents. In the present study, we took advantage of the peptide aptamer strategy to target Nr-13, a Bcl-2 antiapoptotic protein involved in neoplastic transformation by the Rous sarcoma virus. We isolated peptide aptamers that behave as Nr-13 regulators, in vitro and in mammalian cells in culture. Some of these aptamers have potential proapoptotic activities. These data suggest that peptide aptamers targeting the Bcl-2 family of apoptosis inhibitors may be useful for the development of anticancer molecules.
Insights
Researchers developed peptide aptamers targeting Nr-13, a Bcl-2 protein, to combat chemoresistant tumors. These aptamers show potential in regulating Nr-13 and inducing cancer cell death, offering new anticancer therapeutic strategies.
Area of Science:
- Molecular Biology
- Cancer Research
- Drug Discovery
Background:
- Tumor cells exhibit uncontrolled proliferation and resistance to apoptosis.
- Overexpression of Bcl-2 family antiapoptotic proteins is common in chemoresistant cancers.
- Inhibiting these proteins may sensitize cancer cells to chemotherapy.
Purpose of the Study:
- To investigate peptide aptamers as regulators of Nr-13, a Bcl-2 antiapoptotic protein.
- To explore the potential of these aptamers in sensitizing cancer cells to chemotherapy.
- To develop novel anticancer molecules targeting the Bcl-2 family.
Main Methods:
- Utilized peptide aptamer strategy to target Nr-13.
- Isolated and characterized peptide aptamers in vitro and in cultured mammalian cells.
- Assessed the regulatory and proapoptotic activities of isolated aptamers.
Main Results:
- Successfully isolated peptide aptamers that regulate Nr-13 activity.
- Demonstrated that some aptamers possess potential proapoptotic effects.
- Confirmed the efficacy of aptamers in both in vitro and cell culture models.
Conclusions:
- Peptide aptamers targeting Nr-13 can modulate its function.
- Targeting Bcl-2 family proteins with aptamers shows promise for cancer therapy.
- These findings support the development of novel anticancer agents based on peptide aptamers.
